Literature DB >> 656227

Diazoxide in treatment of primary pulmonary hypertension.

S W Wang, J E Pohl, D J Rowlands, E G Wade.   

Abstract

Three patients with primary pulmonary hypertension and one man with suspected thromboembolic pulmonary hypertension were given up to 300 mg diazoxide by injection into the pulmonary artery. The three patients with primary pulmonary hypertension responded with a fall in total pulmonary resistance and a rise in cardiac output. The patient with suspected thromboembolic pulmonary hypertension did not respond. Haemodynamic and clinical improvement was maintained by oral diazoxide in two of the responders, and in one the prognosis appeared to be greatly improved.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656227      PMCID: PMC483448          DOI: 10.1136/hrt.40.5.572

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

Review 1.  Diazoxide.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

2.  Diazoxide--an effective vasodilator in accelerated hypertension.

Authors:  M Moser
Journal:  Am Heart J       Date:  1974-06       Impact factor: 4.749

3.  Diazoxide blood levels in man.

Authors:  S Symchowicz; L Winston; J Black; M Smith; B Calesnick; I I Tabachnick
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

4.  Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.

Authors:  J E Pohl; H Thurston; D Davis; M Y Morgan
Journal:  Br Med J       Date:  1972-06-03

5.  Regression of primary pulmonary hypertension.

Authors:  P D Bourdillon; C M Oakley
Journal:  Br Heart J       Date:  1976-03

6.  Use of diazoxide in hypertension with renal failure.

Authors:  J E Pohl; H Thurston
Journal:  Br Med J       Date:  1971-10-16
  6 in total
  21 in total

Review 1.  Pulmonary arterial hypertension: classification, diagnosis and contemporary management.

Authors:  D J Fox; R S Khattar
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

2.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

Review 3.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

4.  Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog.

Authors:  P J Kadowitz; P Nandiwada; C A Gruetter; L J Ignarro; A L Hyman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  Remission of primary pulmonary hypertension during treatment with diazoxide.

Authors:  D R Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

6.  Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

Authors:  J F Ackroyd
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

Review 7.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

8.  Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

Authors:  L J Rubin; J D Lazar
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

10.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  N S Chan; J McLay; A C Kenmure
Journal:  Br Heart J       Date:  1987-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.